Literature DB >> 25896650

Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization.

Geoff Daniels1, Bryan A Ballif2, Virginie Helias3, Carole Saison3, Shane Grimsley1, Lucienne Mannessier4, Hein Hustinx5, Edmond Lee6, Jean-Pierre Cartron3, Thierry Peyrard7, Lionel Arnaud3.   

Abstract

The Augustine-negative alias At(a-) blood type, which seems to be restricted to people of African ancestry, was identified half a century ago but remains one of the last blood types with no known genetic basis. Here we report that a nonsynonymous single nucleotide polymorphism in SLC29A1 (rs45458701) is responsible for the At(a-) blood type. The resulting p.Glu391Lys variation in the last extracellular loop of the equilibrative nucleoside transporter 1 (ENT1; also called SLC29a1) is known not to alter its ability to transport nucleosides and nucleoside analog drugs. Furthermore, we identified 3 individuals of European ancestry who are homozygous for a null mutation in SLC29A1 (c.589+1G>C) and thus have the Augustine-null blood type. These individuals lacking ENT1 exhibit periarticular and ectopic mineralization, which confirms an important role for ENT1/SLC29A1 in human bone homeostasis as recently suggested by the skeletal phenotype of aging Slc29a1(-/-) mice. Our results establish Augustine as a new blood group system and place SLC29A1 as a new candidate gene for idiopathic disorders characterized with ectopic calcification/mineralization.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896650      PMCID: PMC4458803          DOI: 10.1182/blood-2015-03-631598

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Severe delayed hemolytic transfusion reaction secondary to anti-At(a).

Authors:  K L Cash; T Brown; L Sausais; J Uehlinger; L J Reed
Journal:  Transfusion       Date:  1999-08       Impact factor: 3.157

2.  Six additional examples of anti-Ata.

Authors:  M M Gellerman; J McCreary; E Yedinak; M Stroup
Journal:  Transfusion       Date:  1973 Jul-Aug       Impact factor: 3.157

3.  A very frequent red cell antigen Ata.

Authors:  F Applewhaite; V Ginsberg; J Gerena; C A Cunningham; J Gavin
Journal:  Vox Sang       Date:  1967-11       Impact factor: 2.144

4.  Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs.

Authors:  M Griffiths; N Beaumont; S Y Yao; M Sundaram; C E Boumah; A Davies; F Y Kwong; I Coe; C E Cass; J D Young; S A Baldwin
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

5.  Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs.

Authors:  M Sundaram; S Y Yao; J C Ingram; Z A Berry; F Abidi; C E Cass; S A Baldwin; J D Young
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

Review 6.  Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins.

Authors:  J D Young; S Y M Yao; L Sun; C E Cass; S A Baldwin
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

7.  Anti-Ata causing mild hemolytic disease of the newborn.

Authors:  P L Culver; D B Brubaker; R E Sheldon; M Martin; C A Richter
Journal:  Transfusion       Date:  1987 Nov-Dec       Impact factor: 3.157

8.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification.

Authors:  Frank Rutsch; Nico Ruf; Sucheta Vaingankar; Mohammad R Toliat; Anita Suk; Wolfgang Höhne; Galen Schauer; Mandy Lehmann; Tony Roscioli; Dirk Schnabel; Jörg T Epplen; Alex Knisely; Andrea Superti-Furga; James McGill; Marco Filippone; Alan R Sinaiko; Hillary Vallance; Bernd Hinrichs; Wendy Smith; Merry Ferre; Robert Terkeltaub; Peter Nürnberg
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

9.  The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-/- mouse erythrocytes.

Authors:  Christopher J Endres; Aaron M Moss; Ban Ke; Rajgopal Govindarajan; Doo-Sup Choi; Robert O Messing; Jashvant D Unadkat
Journal:  J Pharmacol Exp Ther       Date:  2009-01-22       Impact factor: 4.030

10.  Aberrant bone density in aging mice lacking the adenosine transporter ENT1.

Authors:  David J Hinton; Meghan E McGee-Lawrence; Moonnoh R Lee; Hoi K Kwong; Jennifer J Westendorf; Doo-Sup Choi
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more
  18 in total

1.  A new polymerase chain reaction: sequence-specific primer method for the Augustine blood type.

Authors:  Oytip Nathalang; Kamphon Intharanut; Wiradee Sasikarn; Siriporn Nathalang; Pawinee Kupatawintu
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

Review 2.  Regulation of bone and cartilage by adenosine signaling.

Authors:  Lauren C Strazzulla; Bruce N Cronstein
Journal:  Purinergic Signal       Date:  2016-07-29       Impact factor: 3.765

Review 3.  Basic calcium phosphate crystal-associated musculoskeletal syndromes: an update.

Authors:  Ann K Rosenthal
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

4.  International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

Authors:  J R Storry; L Castilho; Q Chen; G Daniels; G Denomme; W A Flegel; C Gassner; M de Haas; C Hyland; M Keller; C Lomas-Francis; J M Moulds; N Nogues; M L Olsson; T Peyrard; C E van der Schoot; Y Tani; N Thornton; F Wagner; S Wendel; C Westhoff; V Yahalom
Journal:  ISBT Sci Ser       Date:  2016-06-27

5.  Label-Free Neuroproteomics of the Hippocampal-Accumbal Circuit Reveals Deficits in Neurotransmitter and Neuropeptide Signaling in Mice Lacking Ethanol-Sensitive Adenosine Transporter.

Authors:  Alfredo Oliveros; Phillip Starski; Daniel Lindberg; Sun Choi; Carrie J Heppelmann; Surendra Dasari; Doo-Sup Choi
Journal:  J Proteome Res       Date:  2017-02-27       Impact factor: 4.466

Review 6.  Augustine Blood Group System and Equilibrative Nucleoside Transporter 1.

Authors:  Geoff Daniels
Journal:  Transfus Med Hemother       Date:  2021-12-07       Impact factor: 3.747

7.  Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation.

Authors:  Slim Azouzi; Mahmoud Mikdar; Patricia Hermand; Emilie-Fleur Gautier; Virginie Salnot; Alexandra Willemetz; Gaël Nicolas; Cédric Vrignaud; Alexandre Raneri; Patrick Mayeux; Christine Bole-Feysot; Patrick Nitschké; Jean-Pierre Cartron; Yves Colin; Olivier Hermine; Gabriele Jedlitschky; Marc Cloutier; Jessica Constanzo-Yanez; Carole Ethier; Nancy Robitaille; Maryse St-Louis; Caroline Le Van Kim; Thierry Peyrard
Journal:  Blood       Date:  2020-02-06       Impact factor: 22.113

Review 8.  Bone Marrow Adipose Tissue and Skeletal Health.

Authors:  Shanmugam Muruganandan; Rajgopal Govindarajan; Christopher J Sinal
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

9.  Ectopic mineralisation of the mandibular symphysis in ENT1 knockout mice: A model of dystrophic calcification.

Authors:  Dale E Fournier; Kim L Beaucage; Ryan J Beach; Patti K Kiser; Cheryle A Séguin; S Jeffrey Dixon
Journal:  Bone Rep       Date:  2021-06-18

10.  The equilibrative nucleoside transporter ENT1 is critical for nucleotide homeostasis and optimal erythropoiesis.

Authors:  Mahmoud Mikdar; Pedro González-Menéndez; Xiaoli Cai; Yujin Zhang; Marion Serra; Abdoul K Dembele; Anne-Claire Boschat; Sylvia Sanquer; Cerina Chhuon; Ida Chiara Guerrera; Marc Sitbon; Olivier Hermine; Yves Colin; Caroline Le Van Kim; Sandrina Kinet; Narla Mohandas; Yang Xia; Thierry Peyrard; Naomi Taylor; Slim Azouzi
Journal:  Blood       Date:  2021-06-24       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.